Vehicle foam
Vehicle foam is a pharmaceutical drug with 34 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 33 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
7
Mid Stage
25
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
33 of 33 finished
0.0%
0 ended early
0
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
Clinical Trials (34)
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
Trial of PDE4 Inhibition With Roflumilast (ARQ-154) Foam 0.3% for the Management of Seborrheic Dermatitis (STRATUM)
Safety and Efficacy of ARQ-154 Foam in Subjects With Seborrheic Dermatitis
Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea
A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
Safety and Efficacy of ARQ-154 Foam in Adolescent and Adult Subjects With Scalp and Body Psoriasis
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color
A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis
A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris
A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis
Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea
Safety and Efficacy of Azelaic Acid Foam, 15% in Papulopustular Rosacea
An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis
A Study to Evaluate Safety and Equivalence of Generic Azelaic Acid Foam and Finacea® Foam in Participants With Rosacea
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 34